From a patient who recovered from COVID-19, scientists have isolated a pair of neutralising antibodies that could potentially block the virus responsible for the pandemic from entering into host cells. The study, published in the journal Science, suggests that a "cocktail" containing both antibodies could provide direct therapeutic benefits for COVID-19 patients.

From a patient who recovered from #COVID19, scientists have isolated a pair of neutralising antibodies that could potentially block the virus responsible for the pandemic from entering into host cells.#COVID #COVID19Pandemic pic.twitter.com/VbT3HZ6hVz

— IANS Tweets (@ians_india) May 14, 2020

The new information detailed in the study could also aid the development of small molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus which causes COVID-19. The twin antibodies identified by the researchers are named B38 and H4.